Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    December 2018
  1. KATER AP, Seymour JF, Hillmen P, Eichhorst B, et al
    Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study.
    J Clin Oncol. 2018 Dec 3:JCO1801580. doi: 10.1200/JCO.18.01580.
    PubMed     Text format     Abstract available


  2. DE HAAS V, Ismaila N, Advani A, Arber DA, et al
    Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.
    J Clin Oncol. 2018 Dec 3:JCO1801468. doi: 10.1200/JCO.18.01468.
    PubMed     Text format     Abstract available


    November 2018
  3. ARMENIAN SH, Ehrhardt MJ
    Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes.
    J Clin Oncol. 2018 Nov 13:JCO1801421. doi: 10.1200/JCO.18.01421.
    PubMed     Text format     Abstract available


    October 2018
  4. CARRAWAY HE
    Improving Overall Survival in Older Adults With Acute Myeloid Leukemia: Subpopulations Matter.
    J Clin Oncol. 2018 Oct 2:JCO2018793539. doi: 10.1200/JCO.2018.79.3539.
    PubMed     Text format    


  5. FLOWERS CR, Ramsey SD
    What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?
    J Clin Oncol. 2018 Oct 2:JCO2018793570. doi: 10.1200/JCO.2018.79.3570.
    PubMed     Text format    


    September 2018
  6. BASSAN R, Bourquin JP, DeAngelo DJ, Chiaretti S, et al
    New Approaches to the Management of Adult Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 Sep 21:JCO2017773648. doi: 10.1200/JCO.2017.77.3648.
    PubMed     Text format     Abstract available


  7. LIN JK, Lerman BJ, Barnes JI, Boursiquot BC, et al
    Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 Sep 13:JCO2018790642. doi: 10.1200/JCO.2018.79.0642.
    PubMed     Text format     Abstract available


    August 2018
  8. WINTER SS, Dunsmore KP, Devidas M, Wood BL, et al
    Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
    J Clin Oncol. 2018 Aug 23:JCO2018777250. doi: 10.1200/JCO.2018.77.7250.
    PubMed     Text format     Abstract available


    July 2018
  9. YEOH AEJ, Lu Y, Chin WHN, Chiew EKH, et al
    Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study.
    J Clin Oncol. 2018 Jul 25:JCO2018783050. doi: 10.1200/JCO.2018.78.3050.
    PubMed     Text format     Abstract available


  10. LANCET JE, Uy GL, Cortes JE, Newell LF, et al
    CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.
    J Clin Oncol. 2018 Jul 19:JCO2017776112. doi: 10.1200/JCO.2017.77.6112.
    PubMed     Text format     Abstract available


    June 2018
  11. HUGUET F, Chevret S, Leguay T, Thomas X, et al
    Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.
    J Clin Oncol. 2018 Jun 4:JCO2017768192. doi: 10.1200/JCO.2017.76.8192.
    PubMed     Text format     Abstract available


    May 2018
  12. ROSS DM, Burbury KL, Grigg AP, Hughes TP, et al
    Management of Pregnancy in Women With Chronic Myeloid Leukemia.
    J Clin Oncol. 2018 May 31:JCO2018786137. doi: 10.1200/JCO.2018.78.6137.
    PubMed     Text format    


  13. VAREDI M, Lu L, Howell CR, Partin RE, et al
    Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 May 29:JCO2017767871. doi: 10.1200/JCO.2017.76.7871.
    PubMed     Text format     Abstract available


  14. SLAYTON WB, Schultz KR, Kairalla JA, Devidas M, et al
    Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
    J Clin Oncol. 2018 May 29:JCO2017767228. doi: 10.1200/JCO.2017.76.7228.
    PubMed     Text format     Abstract available


  15. LETAI A
    Targeting B-Cell Lymphoma 2: A Lethal Shortcut in Del(17p) Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2018 May 22:JCO2018782763. doi: 10.1200/JCO.2018.78.2763.
    PubMed     Text format    


  16. FISHER R
    Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.
    J Clin Oncol. 2018 May 3:JCO2018781534. doi: 10.1200/JCO.2018.78.1534.
    PubMed     Text format    


  17. PICCARDO A, Puntoni M, Verburg FA, Luster M, et al
    Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia.
    J Clin Oncol. 2018 May 3:JCO2018777318. doi: 10.1200/JCO.2018.77.7318.
    PubMed     Text format    


  18. STILGENBAUER S, Eichhorst B, Schetelig J, Hillmen P, et al
    Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.
    J Clin Oncol. 2018 May 1:JCO2017766840. doi: 10.1200/JCO.2017.76.6840.
    PubMed     Text format     Abstract available


    April 2018
  19. MORITA K, Kantarjian HM, Wang F, Yan Y, et al
    Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
    J Clin Oncol. 2018 Apr 27:JCO2017776757. doi: 10.1200/JCO.2017.77.6757.
    PubMed     Text format     Abstract available


  20. WALTER RB
    Minimal Residual Disease Testing After Induction Chemotherapy for Acute Myeloid Leukemia: Moving Beyond Prognostication?
    J Clin Oncol. 2018 Apr 6:JCO2018783266. doi: 10.1200/JCO.2018.78.3266.
    PubMed     Text format    


    March 2018
  21. FREEMAN SD, Hills RK, Virgo P, Khan N, et al
    Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.
    J Clin Oncol. 2018 Mar 30:JCO2017763425. doi: 10.1200/JCO.2017.76.3425.
    PubMed     Text format     Abstract available


  22. GORE L, Kearns PR, de Martino Lee ML, De Souza CA, et al
    Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
    J Clin Oncol. 2018 Mar 2:JCO2017759597. doi: 10.1200/JCO.2017.75.9597.
    PubMed     Text format     Abstract available


  23. STANULLA M, Dagdan E, Zaliova M, Moricke A, et al
    IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 Mar 2:JCO2017743617. doi: 10.1200/JCO.2017.74.3617.
    PubMed     Text format     Abstract available


    February 2018
  24. BERMAN E, Druker BJ, Burwick R
    Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy.
    J Clin Oncol. 2018 Feb 15:JCO2017772574. doi: 10.1200/JCO.2017.77.2574.
    PubMed     Text format    


  25. BHAYADIA R, Krowiorz K, Haetscher N, Jammal R, et al
    Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    J Clin Oncol. 2018 Feb 12:JCO2017752204. doi: 10.1200/JCO.2017.75.2204.
    PubMed     Text format     Abstract available


    January 2018
  26. SAKAMOTO K, Imamura T, Kihira K, Suzuki K, et al
    Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group.
    J Clin Oncol. 2018 Jan 23:JCO2017755066. doi: 10.1200/JCO.2017.75.5066.
    PubMed     Text format     Abstract available


  27. QIAN M, Cao X, Devidas M, Yang W, et al
    TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
    J Clin Oncol. 2018 Jan 4:JCO2017755215. doi: 10.1200/JCO.2017.75.5215.
    PubMed     Text format     Abstract available


    December 2017
  28. SOIFFER RJ, Kim HT, McGuirk J, Horwitz ME, et al
    Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplanta
    J Clin Oncol. 2017;35:4003-4011.
    PubMed     Text format     Abstract available


  29. SHAH NP
    Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia.
    J Clin Oncol. 2017 Dec 5:JCO2017754663. doi: 10.1200/JCO.2017.75.4663.
    PubMed     Text format     Abstract available


    November 2017
  30. SCHRAPPE M, Bleckmann K, Zimmermann M, Biondi A, et al
    Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
    J Clin Oncol. 2017 Nov 17:JCO2017744946. doi: 10.1200/JCO.2017.74.4946.
    PubMed     Text format     Abstract available


  31. HUNGER SP
    Integrated Risk Stratification Using Minimal Residual Disease and Sentinel Genetic Alterations in Pediatric Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2017 Nov 13:JCO2017760504. doi: 10.1200/JCO.2017.76.0504.
    PubMed     Text format    


  32. O'CONNOR D, Enshaei A, Bartram J, Hancock J, et al
    Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2017 Nov 13:JCO2017740449. doi: 10.1200/JCO.2017.74.0449.
    PubMed     Text format     Abstract available


  33. OPAT S, Hawkes EA
    Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.
    J Clin Oncol. 2017 Nov 3:JCO2017754721. doi: 10.1200/JCO.2017.75.4721.
    PubMed     Text format    


  34. CORTES JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, et al
    Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
    J Clin Oncol. 2017 Nov 1:JCO2017747162. doi: 10.1200/JCO.2017.74.7162.
    PubMed     Text format     Abstract available


    October 2017
  35. LIM EL, Trinh DL, Ries RE, Wang J, et al
    MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
    J Clin Oncol. 2017 Oct 25:JCO2017747451. doi: 10.1200/JCO.2017.74.7451.
    PubMed     Text format     Abstract available


    September 2017
  36. OSTGARD LSG, Norgaard M, Medeiros BC, Friis LS, et al
    Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
    J Clin Oncol. 2017 Sep 11:JCO2017736728. doi: 10.1200/JCO.2017.73.6728.
    PubMed     Text format     Abstract available


    August 2017
  37. WANG R, Zeidan AM, Halene S, Xu X, et al
    Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life.
    J Clin Oncol. 2017 Aug 7:JCO2017727149. doi: 10.1200/JCO.2017.72.7149.
    PubMed     Text format     Abstract available


  38. KUTNY MA, Alonzo TA, Gerbing RB, Wang YC, et al
    Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.
    J Clin Oncol. 2017 Aug 2:JCO2016716183. doi: 10.1200/JCO.2016.71.6183.
    PubMed     Text format     Abstract available


    July 2017
  39. BROWN JR, Kay NE
    Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2017 Jul 25:JCO2017726810. doi: 10.1200/JCO.2017.72.6810.
    PubMed     Text format    


  40. TURTLE CJ, Hay KA, Hanafi LA, Li D, et al
    Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
    J Clin Oncol. 2017 Jul 17:JCO2017728519. doi: 10.1200/JCO.2017.72.8519.
    PubMed     Text format     Abstract available


  41. TEEPEN JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol. 2017;35:2288-2298.
    PubMed     Text format     Abstract available


  42. HARDY KK, Embry L, Kairalla JA, Helian S, et al
    Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 Jul 3:JCO2016717587. doi: 10.1200/JCO.2016.71.7587.
    PubMed     Text format     Abstract available


  43. KROGER N, Iacobelli S, Franke GN, Platzbecker U, et al
    Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).
    J Clin Oncol. 2017;35:2157-2164.
    PubMed     Text format     Abstract available


    June 2017
  44. LEONARD JP, Martin P, Roboz GJ
    Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    J Clin Oncol. 2017 Jun 27:JCO2017726745. doi: 10.1200/JCO.2017.72.6745.
    PubMed     Text format     Abstract available


  45. LAMBA JK, Chauhan L, Shin M, Loken MR, et al
    CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
    J Clin Oncol. 2017 Jun 23:JCO2016712513. doi: 10.1200/JCO.2016.71.2513.
    PubMed     Text format     Abstract available


  46. LEE JH, Kim H, Joo YD, Lee WS, et al
    Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
    J Clin Oncol. 2017 Jun 20:JCO2017728618. doi: 10.1200/JCO.2017.72.8618.
    PubMed     Text format     Abstract available


  47. BOND J, Graux C, Lhermitte L, Lara D, et al
    Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    J Clin Oncol. 2017 Jun 12:JCO2016718585. doi: 10.1200/JCO.2016.71.8585.
    PubMed     Text format     Abstract available


  48. NABHAN C, Mato AR
    Economic Modeling of the Cost of Chronic Lymphocytic Leukemia Therapy: It Is About the Model.
    J Clin Oncol. 2017;35:1863-1864.
    PubMed     Text format    


    May 2017
  49. WINICK N, Devidas M, Chen S, Maloney K, et al
    Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 May 23:JCO2016714774. doi: 10.1200/JCO.2016.71.4774.
    PubMed     Text format     Abstract available


  50. RITCHIE EK, Guerin A, Wolff J, Joseph G, et al
    Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia.
    J Clin Oncol. 2017;35:1744-1745.
    PubMed     Text format    


  51. BOUDREAU JE, Giglio F, Gooley TA, Stevenson PA, et al
    KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
    J Clin Oncol. 2017 May 18:JCO2016707059. doi: 10.1200/JCO.2016.70.7059.
    PubMed     Text format     Abstract available


  52. PARK S, Hamel JF, Toma A, Kelaidi C, et al
    Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
    J Clin Oncol. 2017;35:1591-1597.
    PubMed     Text format     Abstract available


  53. SEKERES MA, Othus M, List AF, Odenike O, et al
    Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.
    J Clin Oncol. 2017 May 9:JCO2015662510. doi: 10.1200/JCO.2015.66.2510.
    PubMed     Text format     Abstract available


    April 2017
  54. SCOTT BL, Pasquini MC, Logan BR, Wu J, et al
    Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    J Clin Oncol. 2017;35:1154-1161.
    PubMed     Text format     Abstract available


  55. BRADSTOCK KF, Link E, Di Iulio J, Szer J, et al
    Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
    J Clin Oncol. 2017 Apr 3:JCO2016706374. doi: 10.1200/JCO.2016.70.6374.
    PubMed     Text format     Abstract available


  56. ADRA N, Abonour R, Althouse SK, Albany C, et al
    High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
    J Clin Oncol. 2017;35:1096-1102.
    PubMed     Text format     Abstract available


    March 2017
  57. MARTINELLI G, Boissel N, Chevallier P, Ottmann O, et al
    Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter St
    J Clin Oncol. 2017 Mar 29:JCO2016693531. doi: 10.1200/JCO.2016.69.3531.
    PubMed     Text format     Abstract available


  58. LANDIER W, Hageman L, Chen Y, Kornegay N, et al
    Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
    J Clin Oncol. 2017 Mar 24:JCO2016717579. doi: 10.1200/JCO.2016.71.7579.
    PubMed     Text format     Abstract available


    February 2017
  59. WOYACH JA, Ruppert AS, Guinn D, Lehman A, et al
    BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2017 Feb 13:JCO2016702282. doi: 10.1200/JCO.2016.70.2282.
    PubMed     Text format     Abstract available


  60. HOFFMAN KR
    How Does One Decide Which Tyrosine Kinase Inhibitor To Use for the Initial Treatment of Chronic-Phase Chronic Myeloid Leukemia?
    J Clin Oncol. 2017;35:567.
    PubMed     Text format    


    January 2017
  61. GIBSON CJ, Lindsley RC, Tchekmedyian V, Mar BG, et al
    Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
    J Clin Oncol. 2017 Jan 9:JCO2016716712.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: